Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
angiogenesis The natural path to relief is already naturally occurring in the equine body
That reduces how often the primary vial is pierced and helps limit the warm-cold cycling that can contribute to instability
Copper-mediated antioxidant-pathway activity and comparative stability of the three peptides
Fortified Foods: Many breakfast cereals, plant-based milks, and nutritional yeast are fortified with B12, offering great options for those on a plant-based diet
)
)
